Telomerase Upregulation Induces Progression of Mouse BrafV600E-Driven Thyroid Cancers and Triggers Nontelomeric Effects.

Abstract

Telomerase-driven cancer progression activates pathways that can be dissected and perhaps therapeutically exploited.

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Journal: Cell Growth & Differentiation	Publication Date: Jul 21, 2023
Citations: 6	License type: cc-by